Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) ...
Celltrion, a major South Korean biopharmaceutical firm, said on Tuesday its two new bio-similars for bone disease treatment ...
South Korean biopharmaceutical giant Celltrion announced on Tuesday that its two new biosimilars for bone disease treatment have received approval from the United States Food and Drug Administration ...
SEOUL -- Forty-one ferry sailings and four flights were canceled nationwide Tuesday, anti-disaster authorities said, amid ...
SEOUL, March 4 (Yonhap) -- South Korean stocks fell for the third consecutive session Tuesday, as U.S. President Donald Trump ...
Activist shareholders have been rarely visible ahead of the shareholders' meetings of listed companies later this month, a ...
Teens often spend hours daily watching videos online, but parents should consider how the content affects their well-being ...
Korea Joongang Daily on MSN8h
Kospi opens higher despite Trump's planned tariffs on Canada, MexicoKorean stocks opened slightly higher Tuesday, despite U.S. President Donald Trump's planned imposition of tariffs on Canadian ...
Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, today announced the successful first close of its Series B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback